All lobbying filings

G2G Consulting

G2G Consulting filed a Q2 report for Shepherd Therapeutics on July 20, 2026.

Lobbying for Shepherd Therapeutics · rare cancer R&D

As filed: G2G CONSULTING for SHEPHERD THERAPEUTICS.

All filings by G2G Consulting · Everything Shepherd Therapeutics has reported

Filing · LD-2 quarterly report Q2 report

Reporting period

2nd Quarter 2026

Apr 1 - June 30 · Posted Jul 20, 2026

Money reported

None

Registrations and no-activity reports carry no figure.

Client based in

Massachusetts

Official filing document

Lobbyists on this filing 3

ELIZABETH POWELL

Previously held: Legislative Director for Rep. Jim Langevin 2001-2002 and Legislative Director for Rep. Juanita Millender-McDonald 1997-2001
KATHERINE M COLLINS

Previously held: Deputy Director of Operations, The Executive Residence, Executive Office of the President (2011-2016) and Policy Associate, White House Cancer Moonshot Task Force, Office of the Vice President, Executive Office of the President (2016-2017)
CHRISTOPHER WILLIAM COOPER

Previously held: Chief Appropriations Counsel,Chief of Staff,Legislative Director,Senior Legislative Assistant,Legislative Assistant for David Joyce (2013-2023) & Legislative Assistant/ Correspondent,Staff Assistant,Legislative Intern for Steven LaTourette(2011-2013)

A "covered position" is a government job the lobbyist held in the 20 years before registering, which the law requires them to name. See the revolving door for former members of Congress across all filings.

Government bodies contacted 2

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 2

Defense

regarding funding and awareness of rare cancers

Veterans

regarding funding and awareness of rare cancers

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.